Can detection of xenotropic murine leukemia virus-related virus be linked to chronic fatigue syndrome?

References

• Lombardi VC, Ruscetti FW, Das Gupta J et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science326, 585–589 (2009).
   PubMed Web of Science ®Google Scholar
• Urisman A, Molinaro RJ, Fisher N et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog.2, 211–225 (2006).
   Web of Science ®Google Scholar
• Casey G, Neville PJ, Plummer SJ et al.RNASEL Arg462Gin variant is implicated in up to 13% of prostate cancer cases. Nat. Genet.32, 581–583 (2002).
   PubMed Web of Science ®Google Scholar
• Maier C, Haeusler J, Herkommer K et al. Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br. J. Cancer92, 1159–1164 (2005).
   PubMed Web of Science ®Google Scholar
• Schlaberg R, Choe DJ, Brown KR et al. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc. Natl Acad. Sci. USA106, 16351–16356 (2009).
   PubMed Web of Science ®Google Scholar
• Fischer N, Hellwinkel O, Schulz C et al. Prevalence of human g retrovirus XMRV in sporadic prostate cancer. J. Clin. Virol.43, 277–283 (2008).
   PubMed Web of Science ®Google Scholar
• D’Arcy FR, Foley A, Perry L et al. No evidence of XMRV in Irish prostate cancer patients with the R462Q mutations. Eur. Urology Suppl.7, 271 (2008).
   Google Scholar
• Hohn O, Krause H, Barbarotto P et al. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology6, 92 (2009).
   PubMed Web of Science ®Google Scholar
• Hlela C, Shepperd S, Khumalo NP et al. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev.11, 205–214 (2009).
   PubMed Web of Science ®Google Scholar
• Suhadolnik RJ, Reichenbach NL, Hitzges P et al. Upregulation of the 2–5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin. Infect. Dis.18(Suppl. 1), S96–S104 (1994).
   PubMed Web of Science ®Google Scholar
• Gow J, Simpson K, Behan P et al. Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin. Infect. Dis.33, 2080–2081 (2001).
   PubMed Web of Science ®Google Scholar
• Holmes G, Kaplan J, Stewart J et al. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein–Barr virus the cause?. J. Am. Med. Assoc.257, 2297–2303 (1987).
   PubMed Web of Science ®Google Scholar
• Buchwald D, Cheney P, Petersen D et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes type 6 infection. Ann. Intern. Med.116, 103–116 (1992).
   PubMed Web of Science ®Google Scholar
• De Freitas E, Hilliard B, Cheney PR et al. Retroviral sequences related to human T-lymphotropic virus type 11 in patients with chronic fatigue immune dysfunction syndrome. Proc. Natl Acad. Sci. USA88, 2922–2926 (1991).
   PubMed Web of Science ®Google Scholar
• Gow J, Simpson K, Schliephake A et al. Search for retrovirus in the chronic fatigue syndrome. J. Clin. Pathol.45, 1058–1061 (1992).
   PubMed Web of Science ®Google Scholar
• Honda M, Kitamura K, Nakasone T et al. Japanese patients with chronic fatigue syndrome are negative for known retrovirus infections. Microbiol. Immunol.37, 779–784 (1993).
   PubMed Web of Science ®Google Scholar
• Folks TM, Heneine W, Khan A et al. Investigation of retroviral involvement in chronic fatigue syndrome. Ciba. Found. Symp.173, 160–166 (1993).
   PubMedGoogle Scholar
• Khan AS, Heneine WM, Chapman LE et al. Assessment of retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann. Intern. Med.118, 241–245 (1993).
   PubMed Web of Science ®Google Scholar
• Heneine W, Woods TC, Sinha SD et al. Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome. Clin. Infect. Dis.1(Suppl.), S121–S125 (1994).
   Google Scholar
• Erlwein O, Kaye S, McClure MO et al. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS ONE5, e8519 (2010).
   PubMed Web of Science ®Google Scholar
• Groom HC, Boucherit VC, Makinson K et al. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology DOI: 10.1186/1742-4690-7-10 (2010) (Epub ahead of print).
   PubMedGoogle Scholar
• van Kuppeveld FJ, de Jong AS, Lanke KH et al. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ340, c1018 (2010).
   Google Scholar
• Vercoulen JH, Swanink CM, Fennis JF et al. Dimensional assessment of chronic fatigue syndrome. J. Psychosom. Res.38, 383–392 (1994).
   PubMed Web of Science ®Google Scholar
• Swanink CM, Vercoulen JH, Galama JM et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J. Infect. Dis.173, 460–463 (1996).
   PubMed Web of Science ®Google Scholar
• Voisset C, Weiss RA, Griffiths DJ. Human RNA “rumor” viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rev.72, 157–196 (2008).
   PubMed Web of Science ®Google Scholar